Loading…

BD Medical (Becton, Dickinson and Company) announced the official opening of its third world-class production base in Yixing, Jiangsu, China. The facility, with a total investment of 1.332 billion RMB, covers 54 mu (3.6 hectares) and 35,000 square meters, and is expected to produce 250 million liters of bottled injections and 400 million prefilled saline syringes annually.
“碧迪医疗20日在沪披露,其在中国的第三座世界级本土生产基地正式投入运营,该基地位于江苏宜兴。”sh.chinanews.com.cn
Summarized from public sources; check the original articles before acting on it.